Galena Biopharma (GALE) Posts Surprise Q4 Profit of 4c/Share

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
• Investing.com’s stocks of the week